ATE481977T1 - Zusammensetzungen zur verhinderung der thrombozytenaggregation - Google Patents

Zusammensetzungen zur verhinderung der thrombozytenaggregation

Info

Publication number
ATE481977T1
ATE481977T1 AT02706353T AT02706353T ATE481977T1 AT E481977 T1 ATE481977 T1 AT E481977T1 AT 02706353 T AT02706353 T AT 02706353T AT 02706353 T AT02706353 T AT 02706353T AT E481977 T1 ATE481977 T1 AT E481977T1
Authority
AT
Austria
Prior art keywords
compositions
preventing
thrombocyte aggregation
aggregation
thrombocyte
Prior art date
Application number
AT02706353T
Other languages
English (en)
Inventor
Reiner Class
Gerald Soslau
Michael Zeppezauer
Original Assignee
Philadelphia Health & Educatio
Symbiotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Health & Educatio, Symbiotec Gmbh filed Critical Philadelphia Health & Educatio
Application granted granted Critical
Publication of ATE481977T1 publication Critical patent/ATE481977T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Detergent Compositions (AREA)
AT02706353T 2001-02-22 2002-02-22 Zusammensetzungen zur verhinderung der thrombozytenaggregation ATE481977T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27075901P 2001-02-22 2001-02-22
PCT/US2002/005157 WO2002067907A1 (en) 2001-02-22 2002-02-22 Compositions and methods for preventing platelet aggregation

Publications (1)

Publication Number Publication Date
ATE481977T1 true ATE481977T1 (de) 2010-10-15

Family

ID=23032680

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02706353T ATE481977T1 (de) 2001-02-22 2002-02-22 Zusammensetzungen zur verhinderung der thrombozytenaggregation

Country Status (6)

Country Link
EP (1) EP1370248B1 (de)
JP (1) JP2004519476A (de)
AT (1) ATE481977T1 (de)
CA (1) CA2439099C (de)
DE (1) DE60237756D1 (de)
WO (1) WO2002067907A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1593385A1 (de) 2004-05-07 2005-11-09 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie mbH Verwendung von Histonen zur Frühdiagnose und/oder Präventivtherapie virusinfizierter lebender Zellen und ein Biochip zur Durchführung der Diagnose
DE102005022319A1 (de) 2005-05-10 2006-11-23 Symbiotec Gesellschaft Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh Verwendung von Histonen zu therapeutischen Zwecken

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126140A (en) * 1988-08-03 1992-06-30 New England Deaconess Hospital Corporation Thrombomodulin-coated bicompatible substance
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
KR100261114B1 (ko) * 1998-01-24 2000-07-01 박종헌 히스톤을 함유하는 류마티스 관절염 치료제 조성물
US6565854B2 (en) * 1998-08-13 2003-05-20 Philadelphia Health And Education Corporation Antimicrobial histone H1 compositions, kits, and methods of use thereof

Also Published As

Publication number Publication date
CA2439099A1 (en) 2002-09-06
DE60237756D1 (de) 2010-11-04
EP1370248B1 (de) 2010-09-22
WO2002067907A1 (en) 2002-09-06
EP1370248A4 (de) 2008-07-16
JP2004519476A (ja) 2004-07-02
EP1370248A1 (de) 2003-12-17
CA2439099C (en) 2011-07-05
HK1064914A1 (en) 2005-02-08

Similar Documents

Publication Publication Date Title
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE445386T1 (de) Polymerische parfümpartikel
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
DE602004010151D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
ATE503461T1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
PL363168A1 (pl) Cyklopentanole, kompozycje zawierające takie związki i sposoby leczenia
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
DE60239210D1 (de) Polymer-ton nanoverbundzusammensetzung
DE60225167D1 (de) Photochrome polymerisierbare zusammensetzungen
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
EP1646684A4 (de) Polymerverkapselung von adenoviren
DE502004003688D1 (de) Pyrazolidin-1,2-dicarbonsäure-1-((phenyl)-amid)-2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
NO20051281D0 (no) Sammensetning for anrikning av naeringsmidler
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
UY28344A1 (es) Nuevos compuestos
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
EP1566446A4 (de) Beta-1,4-mannobiose enthaltendezusammensetzung
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
DE60237756D1 (de) Zusammensetzungen zur verhinderung der thrombozytenaggregation
SE0302361D0 (sv) Inhibering av upptagning av monoamin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties